vs

Side-by-side financial comparison of GoPro, Inc. (GPRO) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

GoPro, Inc. is the larger business by last-quarter revenue ($201.7M vs $151.7M, roughly 1.3× Nutex Health, Inc.). On growth, GoPro, Inc. posted the faster year-over-year revenue change (0.4% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $15.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 13.9%).

GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

GPRO vs NUTX — Head-to-Head

Bigger by revenue
GPRO
GPRO
1.3× larger
GPRO
$201.7M
$151.7M
NUTX
Growing faster (revenue YoY)
GPRO
GPRO
+41.5% gap
GPRO
0.4%
-41.1%
NUTX
More free cash flow
NUTX
NUTX
$54.0M more FCF
NUTX
$69.0M
$15.0M
GPRO
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
13.9%
GPRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GPRO
GPRO
NUTX
NUTX
Revenue
$201.7M
$151.7M
Net Profit
$11.8M
Gross Margin
31.8%
30.4%
Operating Margin
-4.1%
20.4%
Net Margin
7.8%
Revenue YoY
0.4%
-41.1%
Net Profit YoY
-80.8%
EPS (diluted)
$-0.06
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPRO
GPRO
NUTX
NUTX
Q4 25
$201.7M
$151.7M
Q3 25
$162.9M
$267.8M
Q2 25
$152.6M
$244.0M
Q1 25
$134.3M
$211.8M
Q4 24
$200.9M
$257.6M
Q3 24
$258.9M
$78.8M
Q2 24
$186.2M
$76.1M
Q1 24
$155.5M
$67.5M
Net Profit
GPRO
GPRO
NUTX
NUTX
Q4 25
$11.8M
Q3 25
$-21.3M
$55.4M
Q2 25
$-16.4M
$-17.7M
Q1 25
$-46.7M
$21.2M
Q4 24
$61.6M
Q3 24
$-8.2M
$-8.8M
Q2 24
$-47.8M
$-364.0K
Q1 24
$-339.1M
$-364.0K
Gross Margin
GPRO
GPRO
NUTX
NUTX
Q4 25
31.8%
30.4%
Q3 25
35.1%
57.8%
Q2 25
35.8%
51.2%
Q1 25
32.1%
55.9%
Q4 24
34.7%
55.0%
Q3 24
35.5%
27.8%
Q2 24
30.5%
29.7%
Q1 24
34.1%
15.1%
Operating Margin
GPRO
GPRO
NUTX
NUTX
Q4 25
-4.1%
20.4%
Q3 25
-9.8%
48.7%
Q2 25
-9.2%
13.8%
Q1 25
-33.7%
38.1%
Q4 24
-19.5%
44.4%
Q3 24
-3.1%
12.3%
Q2 24
-25.0%
7.0%
Q1 24
-26.6%
2.1%
Net Margin
GPRO
GPRO
NUTX
NUTX
Q4 25
7.8%
Q3 25
-13.0%
20.7%
Q2 25
-10.8%
-7.3%
Q1 25
-34.8%
10.0%
Q4 24
23.9%
Q3 24
-3.2%
-11.2%
Q2 24
-25.7%
-0.5%
Q1 24
-218.1%
-0.5%
EPS (diluted)
GPRO
GPRO
NUTX
NUTX
Q4 25
$-0.06
$2.34
Q3 25
$-0.13
$7.76
Q2 25
$-0.10
$-2.95
Q1 25
$-0.30
$3.33
Q4 24
$-0.22
$11.56
Q3 24
$-0.05
$-1.72
Q2 24
$-0.31
$-0.07
Q1 24
$-2.24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPRO
GPRO
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$49.7M
$185.6M
Total DebtLower is stronger
$44.3M
Stockholders' EquityBook value
$76.5M
$329.4M
Total Assets
$428.0M
$918.5M
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPRO
GPRO
NUTX
NUTX
Q4 25
$49.7M
$185.6M
Q3 25
$152.8M
$166.0M
Q2 25
$58.6M
$96.7M
Q1 25
$69.6M
$84.7M
Q4 24
$102.8M
$40.6M
Q3 24
$130.2M
$46.9M
Q2 24
$133.0M
$40.8M
Q1 24
$133.7M
$30.0M
Total Debt
GPRO
GPRO
NUTX
NUTX
Q4 25
$44.3M
Q3 25
$43.9M
Q2 25
Q1 25
Q4 24
$0
Q3 24
$93.1M
Q2 24
$92.9M
Q1 24
$92.7M
Stockholders' Equity
GPRO
GPRO
NUTX
NUTX
Q4 25
$76.5M
$329.4M
Q3 25
$80.5M
$317.2M
Q2 25
$97.9M
$235.3M
Q1 25
$110.0M
$176.9M
Q4 24
$151.7M
$132.4M
Q3 24
$183.9M
$60.4M
Q2 24
$184.7M
$62.7M
Q1 24
$224.9M
$63.0M
Total Assets
GPRO
GPRO
NUTX
NUTX
Q4 25
$428.0M
$918.5M
Q3 25
$538.6M
$964.5M
Q2 25
$439.0M
$841.0M
Q1 25
$462.5M
$761.9M
Q4 24
$543.7M
$655.3M
Q3 24
$661.6M
$438.5M
Q2 24
$556.8M
$422.4M
Q1 24
$575.8M
$404.3M
Debt / Equity
GPRO
GPRO
NUTX
NUTX
Q4 25
0.58×
Q3 25
0.55×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.51×
Q2 24
0.50×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPRO
GPRO
NUTX
NUTX
Operating Cash FlowLast quarter
$15.6M
$70.4M
Free Cash FlowOCF − Capex
$15.0M
$69.0M
FCF MarginFCF / Revenue
7.4%
45.5%
Capex IntensityCapex / Revenue
0.3%
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$-24.0M
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPRO
GPRO
NUTX
NUTX
Q4 25
$15.6M
$70.4M
Q3 25
$12.2M
$99.5M
Q2 25
$8.8M
$27.3M
Q1 25
$-57.2M
$51.0M
Q4 24
$-25.1M
$54.0K
Q3 24
$-2.2M
$6.8M
Q2 24
$605.0K
$13.3M
Q1 24
$-98.4M
$3.1M
Free Cash Flow
GPRO
GPRO
NUTX
NUTX
Q4 25
$15.0M
$69.0M
Q3 25
$11.2M
$99.2M
Q2 25
$8.3M
$26.5M
Q1 25
$-58.5M
$50.9M
Q4 24
$-25.5M
$-341.0K
Q3 24
$-4.2M
$6.2M
Q2 24
$-111.0K
$12.7M
Q1 24
$-99.4M
$2.3M
FCF Margin
GPRO
GPRO
NUTX
NUTX
Q4 25
7.4%
45.5%
Q3 25
6.9%
37.0%
Q2 25
5.4%
10.9%
Q1 25
-43.5%
24.0%
Q4 24
-12.7%
-0.1%
Q3 24
-1.6%
7.8%
Q2 24
-0.1%
16.7%
Q1 24
-63.9%
3.4%
Capex Intensity
GPRO
GPRO
NUTX
NUTX
Q4 25
0.3%
0.9%
Q3 25
0.6%
0.1%
Q2 25
0.3%
0.3%
Q1 25
1.0%
0.0%
Q4 24
0.2%
0.2%
Q3 24
0.8%
0.8%
Q2 24
0.4%
0.7%
Q1 24
0.6%
1.1%
Cash Conversion
GPRO
GPRO
NUTX
NUTX
Q4 25
5.95×
Q3 25
1.80×
Q2 25
Q1 25
2.40×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPRO
GPRO

Subscription And Services$106.3M53%
Other$95.4M47%

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons